2018 Scientific Sessions Highlights
Expert Debate on CVD Risk Reduction in the Cardiometabolic Patient

Peter H. Jones, MD, FNLA Christie M. Ballantyne, MD, FNLA Robert P. Giugliano, MD, SM Valentina Rodriguez, MD Joseph J. Saseen, PharmD, CLS, FNLA Paul D. Rosenblit MD, PhD, FACE, FNLA
CRISPR-Cas9 genome editing for treatment of atherogenic dyslipidemia

Kiran Musunuru, MD, PhD, MPH
Kiran Musunuru, MD presents his talk on CRISPR-Cas9 genome editing for treatment of atherogenic dyslipidemia at the 2018 Scientific Sessions in Las Vegas, Nevada.
Start Presentation Slides Audio OnlyTags:
Update on Clinical Trials: How Will This Affect Practice in the Future?

Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA
Pamela Morris, MD presents her update on clinical trials at the 2018 Scientific Sessions in Las Vegas, Nevada.
Start Presentation Slides Audio OnlyTags:
Resistant Hypertension: A Practical Approach to the Guidelines

Michael J Bloch, MD, FACP, FASH, FSVM, FNLA
Michael Bloch, MD presents his talk on Resistant Hypertension at the 2018 Scientific Sessions in Las Vegas, Nevada.
Start Presentation Slides Audio OnlyTags: